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DObjective: The aim of our study was to compare the early and long-term outcomes of patients undergoing
off-pump coronary artery bypass grafting (CABG) with and without previous coronary stents.
Methods:Between September 2004 and September 2011, 269 patients with previous stents underwent first-time
isolated off-pump CABG. These patients were compared with 897 patients without previous stent. A propensity
score-matching analysis was performed to compare early and late outcomes between the groups. Mean follow-
up time was 43.4 months after surgery.
Results: Patients with previous stents were more likely to be men (85.9% in the stent group vs 79.4% in the
no-stent group; P ¼ .022) and more likely to have prior myocardial infarction (60.2% vs 36.8%; P<.001).
Mean number of anastomoses was lower in patients with previous stents than in patients without previous stents
(4.0 vs 4.2; P ¼ .037). There was no difference in the use of bilateral internal thoracic artery graft between the
groups (88.8% vs 89.1%; P>.999). After propensity adjustment for preoperative characteristics, both operative
death (0.7% vs 1.5%; P ¼ .414) and the major complications rates (7.8% vs 7.5%; P ¼ .869) were similar
between the groups. The actuarial survival rate at 7 years was not different between the groups (87.2% 
3.2% vs 84.8%  2.9%; P ¼ .470). Furthermore, freedom from major adverse cardiac and cerebrovascular
events at 7 years were similar between the groups (78.9%  3.8% vs 77.6%  3.3%; P ¼ .811).
Conclusions: Previous coronary stents do not increase early and long-term morbidity or mortality in patients
undergoing off-pump CABG. (J Thorac Cardiovasc Surg 2014;148:1843-9)The use of stents during percutaneous coronary intervention
(PCI) for the treatment of coronary artery disease has been
increasing. However, restenosis is still a major problem af-
ter stent implantation. Therefore, the number of patients un-
dergoing coronary artery bypass grafting (CABG) in whom
previous PCI procedures have been performed is also
increasing. Several investigators have demonstrated that
previous PCI with stent is a risk factor of CABG.1-4
Massoudy and colleagues3 showed in a multicenter analysis
that a history of multiple PCIs was an independent predictor
for in-hospital deaths and major adverse cardiac events.3 In
an another multicenter study, Mannacio and colleagues4
demonstrated that a history of PCI before CABG increased
risk for both operative death and perioperative complica-
tions and decreased survival at 5 years’ follow-up. Possible
reasons for the worse outcome after CABG in patients withe Department of Cardiovascular Surgery,a Sakakibara Heart Institute, Tokyo,
; and the EBM Research Center,b Kyoto University Graduate School of
cine, Kyoto, Japan.
ures: Authors have nothing to disclose with regard to commercial support.
d for publication Oct 23, 2013; revisions received Jan 17, 2014; accepted for
cation Feb 4, 2014; available ahead of print March 6, 2014.
for reprints: Toshihiro Fukui, MD, Department of Cardiovascular Surgery,
ibara Heart Institute, 3-16-1 Asahi-cho, Fuchu City, Tokyo 183-0003, Japan
ail: tfukui.cvs@gmail.com).
23/$36.00
ht  2014 by The American Association for Thoracic Surgery
.doi.org/10.1016/j.jtcvs.2014.02.004
The Journal of Thoracic and Carprevious stent compared with those without stent include
local and systemic inflammatory reactions.5,6 Previous
studies comparing outcomes in patients with and without
previous PCI with stent included CABG using
cardiopulmonary bypass, which accelerates systemic
inflammatory responses.7 Thus we hypothesized that the
elimination of cardiopulmonary bypass may diminish the
difference in in-hospital and long-term outcomes among pa-
tients undergoing CABG with and without previous stent.
The aim of our study was to compare the early and long-
term outcomes of patients undergoing off-pump CABG
with and without previous coronary stents.PATIENTS AND METHODS
Study Patients
Between September 2004 and September 2011, 1166 patients under-
went first-time isolated off-pump CABG at the Sakakibara Heart Institute.
Of those, 269 patients (23.1%; stent group) had at least 1 previous PCI with
stent, whereas 897 patients (76.9%; no-stent group) underwent Off-pump
CABG as the first-time intervention for the treatment of coronary artery
disease. In the stent group, the mean number of PCI procedures with stent
per patient was 1.7 1.2 in the stent group (single PCI procedurewith stent
in 162 patients and multiple PCI procedures with stents in 107 patients).
Furthermore, the median interval from the last PCI procedure to the
CABG operation was 12 months (range, 1 day-254 months). The mean
number of implanted stents was 1.8  1.3 per patient. Implanted stent ma-
terial included bare-metal stents in 174 patients, drug-eluting stents in
71patients, and both in 24 patients.diovascular Surgery c Volume 148, Number 5 1843
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
ITA ¼ internal thoracic artery
MACCE ¼ major adverse cardiac and
cerebrovascular event
PCI ¼ percutaneous coronary intervention
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DThe institutional review board of our institution approved this retrospec-
tive study and waived the need for written consent. All data were collected
prospectively and reviewed retrospectively. Follow-up involved direct
communication with the patient, the patient’s family, the attending physi-
cian, or a combination of these.
The primary end point of our study was long-term all-cause mortality,
including early deaths. The secondary end points were operative death,
early major complications, and late major adverse cardiac and cerebrovas-
cular event (MACCE).
Operative Method
Our operative technique for off-pump CABG has been described previ-
ously.8 All arterial grafts were harvested in a skeletonized fashion using an
ultrasonic scalpel (Harmonic Scalpel, Ethicon Endosurgery, Cincinnati,
Ohio). We bypassed all significantly diseased coronary vessels (50%
diameter reduction) which were>1 mm in diameter. Deep pericardial
stay sutures were not used, and a commercially available heart positioner
and stabilizer were applied in all cases. We performed extensive recon-
struction when the left anterior descending artery was diffusely diseased,
and branches such as the septal and diagonal arteries were affected by se-
vere atheromatous plaque. The detailed indications, techniques, and out-
comes of extensive reconstruction of the left anterior descending artery
have been described previously.9
During the operation, graft patency was assessed with a Doppler flow
meter in all patients. Furthermore, intraoperative fluorescence imaging
has been additionally used since April 2007.
We routinely prescribed low-dose aspirin to all patients postoperatively,
continued indefinitely. Clopidogrel was given only in patients with a drug-
eluting stent.
Definitions
Nonelective operations included both emergency and urgent cases, ac-
cording to the definitions in the Society of Thoracic Surgeons database.
Operative death was defined as death occurring during the same hospital-
ization, or after discharge but within 30 days after surgery. Low-output syn-
drome was defined as the postoperative need for intra-aortic balloon
pumping, or any dose of adrenaline, or>5 mg/kg/min dopamine or dobut-
amine. Perioperative myocardial infarction was defined as new Qwaves on
electrocardiography or a peak creatine kinase MB level of5 times the up-
per limit of normal (25 IU/L). Respiratory failure was defined as a require-
ment for prolonged ventilation (>48 hours) or the occurrence of
pneumonia. Postoperative stroke was defined as a new neurological deficit
that was detected on computed tomography. In patients with preoperative
stroke, postoperative stroke was defined as a worsening of the neurologic
deficit with new radiologic findings. The major complications included
low-output syndrome, perioperative myocardial infarction, respiratory fail-
ure, stroke, new requirement of hemodialysis, mediastinitis, and reexplora-
tion due to bleeding. MACCE was defined as death from any cause, stroke,
myocardial infarction, or repeat revascularization.
Statistical Analysis
All statistical analyses were performed using the StatView 5.0 software
package or the SAS program for Windows, release 9.2 (SAS Institute Inc,1844 The Journal of Thoracic and Cardiovascular SurCary, NC). Continuous variables are reported as the mean  standard de-
viation. Continuous variables were compared by Student t test, whereas
discrete variables were compared by the c2 test or Fischer exact test.
Actuarial survival curves were estimated using the Kaplan-Meier
method. The log-rank test was used to assess differences in survival be-
tween groups. Multivariate Cox proportional hazards analysis was per-
formed to identify significant predictors of late mortality and late
MACCE, using the clinical variables listed in Table 1 and the history of pre-
vious stent. Variables withP<.1 in univariate analyses were included in the
multivariate model.
A propensity score of having previous stent was calculated for each pa-
tient using a logistic regression model that included all preoperative vari-
ables listed in Table 1. Patients were matched 1:1 on propensity scores
with greedy matching techniques. Outcomes of interest between the
matched groups were compared using the paired t test for continuous vari-
ables, and the McNemar test for discrete variables.
Power analysis for log-rank test indicated that this study has adequate
power to detect significant differences for the late death (1-b: 0.94; survival
proportion of 7 years of the no-stent group: 0.84; hazard ratio [HR], 0.27)
for an a value of 0.05.
RESULTS
Preoperative Characteristics and In-Hospital
Outcomes
Preoperative characteristics of both groups are shown in
Table 1. The stent group had higher proportions of men
(P ¼ .022) and prior myocardial infarction (P < .001).
The mean number of diseased vessels was higher in the
no-stent group than in the stent group (P ¼ .006).
The intraoperative and postoperative data are listed in
Table 2. The mean number of anastomoses per patient
was significantly higher in the stent group than in the no-
stent group (P ¼ .037). The incidence of performing exten-
sive reconstruction of the left anterior descending artery
was higher in the stent group than in the no-stent group
(P ¼ .003).
The operative death rates did not differ between these
groups (P>.999) and neither did the major complication
(P>.999). The causes of death were mediastinitis in 1 pa-
tient and congestive heart failure in the other patient in the
stent group and pneumonia in 6 patients, congestive heart
failure in 1 patient, and a rupture of aortic aneurysm in 1 pa-
tient in the non-stent group.
Long-Term Outcomes
Follow-up was complete in 1158 of 1166 patients
(99.3%). During the follow-up period (43.4  24.5
months), there were 19 deaths in the stent group and 81
deaths in the no-stent group. The actuarial survival rate at
7 years was 87.3%  3.2% in the stent group and 84.4%
 3.8% in the no-stent group (P¼ .381) (Figure 1, A). Uni-
variate analyses identified that age, smaller body surface
area, acute coronary syndrome, Canadian Cardiovascular
Society class III or IV, lower ejection fraction, number of
diseased vessel, higher creatinine level, a history of conges-
tive heart failure, peripheral vascular disease, chronic
obstructive pulmonary disease, nonelective surgery, andgery c November 2014
TABLE 1. Preoperative characteristics
Characteristic
Non-matched pairs Propensity-matched pairs
Stent (n ¼ 269) No-stent (n ¼ 897) P value Stent (n ¼ 268) No-stent (n ¼ 268) P value
Age (y) 68.0  9.4 68.2  10.5 .786 68.0  9.5 67.3  11.0 .445
Female 38 (14.1) 185 (20.6) .022 38 (14.2) 51 (19.0) .128
Body surface area (m2) 1.7  0.2 1.7  0.2 .882 1.7  0.2 1.6  0.2 .716
Acute coronary syndrome 94 (34.9) 312 (34.8) >.999 93 (34.7) 104 (38.8) .305
Ejection fraction (%) 55.8  11.3 56.1  11.8 .750 55.9  11.3 56.0  11.5 .862
Diseased vessel 2.7  0.5 2.8  0.4 .006 2.7  0.5 2.7  0.5 .718
Left main disease 91 (33.8) 316 (35.2) .727 91 (34.0) 97 (36.2) .587
Creatinine (mg/dL) 1.3  1.8 1.1  1.3 .100 1.3  1.8 1.3  1.9 .805
Congestive heart failure history 37 (13.8) 121 (13.5) .992 36 (13.4) 32 (11.9) .599
Prior myocardial infarction 162 (60.2) 330 (36.8) <.001 161 (60.1) 148 (55.2) .133
Hypertension 176 (65.4) 629 (70.1) .166 175 (65.3) 171 (63.8) .708
Diabetes mellitus 126 (46.8) 419 (46.7) >.999 125 (46.6) 130 (48.5) .641
Hyperlipidemia 170 (63.2) 572 (63.8) .922 169 (63.1) 170 (63.4) .929
Smoking history 166 (61.7) 535 (59.6) .592 166 (61.9) 164 (61.2) .862
Previous stroke 23 (8.6) 102 (11.4) .230 23 (8.6) 31 (11.6) .228
Peripheral vascular disease 25 (9.3) 68 (7.6) .435 25 (9.3) 19 (7.1) .366
Chronic obstructive pulmonary disease 8 (3.0) 34 (3.8) .657 8 (3.0) 2 (0.7) .058
Atrial fibrillation 8 (3.0) 49 (5.5) .134 8 (3.0) 9 (3.4) .808
Values are presented as mean  standard deviation or n (%).
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Datrial fibrillation were associated with late mortality.
Multivariate analysis (Table 3) revealed that age, smaller
body surface area, lower ejection fraction, higher creatinine
level, a history of congestive heart failure, peripheral
vascular disease, chronic obstructive pulmonary disease,
and atrial fibrillation were independent predictors of late
mortality. Previous stent was not identified as an indepen-
dent predictor of late mortality.TABLE 2. Operative and postoperative data
Variable
Non-matched p
Stent (n ¼ 269) No-stent (n
Anastomoses/patient 4.0  1.3 4.2 
Bilateral internal thoracic artery use 239 (88.8) 799 (8
Extensive reconstruction of left anterior
descending artery
78 (29.0) 182 (2
Operation time (min) 278.6  65.0 275.1 
Intraoperative red blood cell transfusion 92 (34.2) 305 (3
Intubation (h) 11.5  24.8 8.9 
Intensive care unit stay (d) 1.7  3.1 1.9 
Operative death 2 (0.7) 8 (0
Major complication 21 (7.8) 69 (7
Low output syndrome 4 (1.5) 17 (1
Perioperative myocardial infarction 2 (0.7) 7 (0
Respiratory failure 10 (3.7) 22 (2
Severe ventricular arrhythmia 1 (0.4) 9 (1
Require hemodialysis 5 (1.9) 12 (1
Stroke 5 (1.9) 12 (1
Mediastinitis 1 (0.4) 9 (1
Reexploration due to bleeding 2 (0.7) 10 (1
Atrial fibrillation 67 (24.9) 233 (2
Values are presented as mean  standard deviation or n (%).
The Journal of Thoracic and CarMACCE were observed in 36 patients in the stent group
and 140 patients in the no-stent group. Freedom from
MACCE at 7 years was 79.1%  3.7% in the stent group
and 76.2%  2.2% in the no-stent group (P ¼ .438)
(Figure 1, B). Univariate analyses identified that age,
smaller body surface area, acute coronary syndrome,
Canadian Cardiovascular Society class III or IV, lower
ejection fraction, number of diseased vessel, higherairs Propensity-matched pairs
¼ 897) P value Stent (n ¼ 268) No-stent (n ¼ 268) P value
1.2 .037 4.0  1.3 4.2  1.2 .283
9.1) >.999 238 (88.8) 235 (87.7) .691
0.3) .003 77 (28.7) 51 (19.0) .012
61.1 .422 278.2  64.8 269.2  57.9 .010
4.0) >.999 92 (34.3) 92 (34.3) >.999
8.3 .008 11.5  24.9 9.1  9.2 .091
8.5 .665 1.7  3.1 2.0  8.3 .672
.9) >.999 2 (0.7) 4 (1.5) .414
.7) >.999 21 (7.8) 20 (7.5) .869
.9) .798 4 (1.5) 8 (3.0) .248
.8) >.999 2 (0.7) 2 (0.7) >.999
.5) .368 10 (3.7) 6 (2.2) .314
.0) .473 1 (0.4) 3 (1.1) .314
.3) .737 5 (1.9) 8 (3.0) .405
.3) .737 5 (1.9) 2 (0.7) .257
.0) .469 1 (0.4) 0 .317
.1) .744 2 (0.7) 2 (0.7) >.999
6.0) .814 67 (25.0) 74 (27.6) .518
diovascular Surgery c Volume 148, Number 5 1845
FIGURE 1. A, Kaplan-Meier event-free survival analysis for all deaths in nonmatched patients. B, Kaplan-Meier event-free survival analysis for major
adverse cardiac and cerebrovascular events in nonmatched patients.
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Dcreatinine level, a history of congestive heart failure,
peripheral vascular disease, chronic obstructive pulmonary
disease, nonelective surgery, and atrial fibrillation were
associated with MACCE. Multivariate analysis (Table 3)
revealed that lower ejection fraction, higher creatinine
level, peripheral vascular disease, and atrial fibrillation
were independent predictors of MACCE. Previous
stent was not identified as an independent predictor of
MACCE.
Propensity Score Matched-Pairs Analysis
Preoperative and perioperative data of the propensity-
matched patients are listed in Tables 1 and 2. These
matched pairs were well balanced for all known covariates
(Table 1). The rate of patients undergoing extensive recon-
struction of the left anterior descending artery were
higher in the stent group than in the no-stent group1846 The Journal of Thoracic and Cardiovascular Sur(P ¼ .012), which lead to the longer operation time in the
stent group than the no-stent group (P ¼ .010).
The operative death rates did not differ between these
groups (P ¼ .414) and neither did the major complication
rates (P ¼ .869).
The actuarial survival rate at 7 years was not different be-
tween the groups (87.2%  3.2% in the stent group and
84.8%  2.9% in the no-stent group; P ¼ .470)
(Figure 2, A). Furthermore, freedom from MACCE at 7
years was not different between the groups (78.9% 
3.8% in stent group and 77.6%  3.3% in the no-stent
group; P ¼ .811) (Figure 2, B).
DISCUSSION
Our study demonstrates that previous PCI with stent does
not increase early morbidity or mortality in patients under-
going off-pump CABG. Moreover, previous coronary stentgery c November 2014
TABLE 3. Multivariate Cox proportional hazard analysis for late
events




Age 1.084 <.001 1.052-1.116
Smaller body surface area 4.878 .002 1.821-13.158
Lower ejection fraction 1.016 .049 1.000-1.033
Creatinine 1.260 <.001 1.156-1.373
History of congestive heart
failure
1.764 .025 1.074-2.899




Atrial fibrillation 2.041 .025 1.096-3.802
Late MACCE
Lower ejection fraction 1.013 .049 1.000-1.027
Creatinine 1.119 .003 1.038-1.206
Peripheral vascular disease 1.848 .006 1.196-2.857
Atrial fibrillation 2.037 .006 1.229-3.367
MACCE, Major adverse cardiac and cerebrovascular event.
Fukui et al Acquired Cardiovascular Disease
A
C
Dwas not an independent predictor of late adverse outcome
after off-pump CABG. Similar results have been reported
by other investigators.10-12 They demonstrated that there
were no differences in mortality or morbidity between
patients undergoing CABG with and without previous
PCI.10-12 Barakate and colleagues10 reported similar
30-day mortality rates (2.0%) for patients undergoing
CABG with and without previous PCI. Van den Brule and
colleagues11 also described no significant differences in
the rates of myocardial infarction, arrhythmia, reinterven-
tions, neurologic complications, renal complications,
pulmonary complications, or in-hospital mortality for pa-
tients undergoing CABG with and without previous PCI.
Furthermore, they reported that a 1-year follow-up did not
reveal any significant differences in the rates of cardiac-
related mortality or recurrent ischemic events between their
groups. More recently, Boening and colleagues12 reported
that coronary stenting in patients with diabetes did not pre-
dispose to a higher perioperative risk regarding mortality
and morbidity after CABG. However, these studies were
limited to demonstrate the early outcomes; moreover,
CABG was performed with cardiopulmonary bypass in
the majority of patients. In our study, we selected patients
undergoing off-pump CABG to eliminate the inflammatory
effect of cardiopulmonary bypass. Furthermore, long-term
outcomes were compared between the groups to investigate
the influence of having a stent on patients’ prognoses.
In contrast, there are several reports demonstrating that
the previous PCI with stent is a risk factor for CABG. Has-
san and colleagues2 reported that the in-hospital mortality
rates after CABG were higher in patients with prior PCI
than in patients without prior PCI (3.6% vs 2.3%). Further-
more, prior PCI emerged as an independent predictor ofThe Journal of Thoracic and Carpostoperative in-hospital mortality. Similarly, Thielmann
and colleagues1 described that multiple previous PCI proce-
dures were strongly associated with in-hospital mortality
(odds ratio, 2.24) andmajor adverse cardiac events (odds ra-
tio, 2.28). More recently, Massoudy and colleagues3
showed in a large multicenter analysis (N ¼ 37,140) that
a history of multiple PCIs was an independent predictor
for in-hospital death and major adverse cardiac events.
Furthermore, Mannacio and colleagues4 demonstrated that
a history of PCI before CABG decreased survival at 5 years’
follow-up. Several negative influences of PCI with stent
have been considered. Lazar13 suggested that stents not
only may result in local vascular inflammation, but also
may stimulate platelet and neutrophil adhesion along the
entire vessel, with resulting decreased graft patency. More-
over, because of the physical presence of the stent, bypass
grafts may need to be inserted more distally in vessels,
which may compromise runoff and ultimately patency.10
In fact, Gomez and colleagues6 found that the coronary
artery distal to the stent had chronic inflammation and an
intimal acute inflammatory infiltrate with polymorphonu-
clear leukocytes. Moreover, the myocardium adjacent to
the stent had significant chronic inflammatory infiltrate
and fibrosis.
The use of cardiopulmonary bypass may amplify these
inflammatory reactions both locally and systemically.
Then the off-pump procedure may contribute to better out-
comes than the on-pump procedure. In a previous study,14
we demonstrated that the in-hospital outcomes and the early
patency rates of grafts were not different between patients
with and without previous PCI who underwent off-pump
CABG. However, in that study, the number of patients
was small (N ¼ 545), and there were no follow-up results.
In our present study, we extended the follow-up to more
than 7 years and further demonstrated that long-term sur-
vival and freedom from major complications were not
affected by previous PCI with stent. Moreover, we adopted
propensity score matched-pairs analysis to minimize the
difference between the groups, which was not done in our
previous study.
In our study, the percentage of use of bilateral internal
thoracic artery (ITA) was higher than in other studies.
Moreover, there was no difference regarding the use of
bilateral ITA between the groups. It is well known that
the use of bilateral ITA provides better survival benefit
than single ITA.15 Furthermore, the combination of
off-pump CABG with bilateral ITA grafting also yields
favorable outcomes.16 We also demonstrated in a previous
study17 that off-pump bilateral ITA grafting can be
performed safely and effectively with favorable early and
1-year patency rates in patients with and without left main
disease. In our study, the potential influence of bilateral
ITA rather than off-pump CABG may have affected
the outcome in both groups, although there was nodiovascular Surgery c Volume 148, Number 5 1847
FIGURE 2. A, Kaplan-Meier event-free survival analysis for all deaths in matched patients. B, Kaplan-Meier event-free survival analysis for major adverse
cardiac and cerebrovascular events in matched patients.
Acquired Cardiovascular Disease Fukui et al
A
C
Ddifference regarding the outcome between the groups. How-
ever, because nonuse of bilateral ITA was not associated
with late mortality (HR, 1.457; 95% confidence interval,
0.859-2.472; P ¼ .163) and MACCE (HR, 1.101; 95%
confidence interval, 0.708-1.713; P ¼ .669) by univariate
analysis, further study is necessary to investigate the
effect of bilateral ITA in patients with and without previous
stents.
Our clinical study has some limitations. The number of
patients was relatively small. Although propensity-
matched comparison was used, it was still a retrospective
observational study and unrecognized confounding factors
may exist. We did not show any patency rates of grafts
in our study because we did not have enough data on
follow-up patency rates of these patients (stent group: 144
out of 268 [53.5%], no-stent group: 479 out of 897
[53.4%]).1848 The Journal of Thoracic and Cardiovascular SurCONCLUSIONS
Previous coronary stents do not increase early and
long-term morbidity or mortality in patients undergoing
off-pump CABG.
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